查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2017769

肠外营养市场规模、份额和趋势分析报告：按营养素、给药阶段、适应症、销售管道、地区和细分市场预测（2026-2033 年）

Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type, By Stage Type, By Indication, By Sales Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10个工作天内

价格

肠外营养市场概述

2025年全球肠外营养市场规模估计为79.7亿美元，预计2033年将达到125.9亿美元。

预计从2026年到2033年，其复合年增长率将达到5.87%。这一增长归因于胃肠道疾病盛行率的上升、早产儿数量的增加以及癌症等慢性疾病发生率的上升。

医院基础设施的扩建、营养配方技术的进步以及居家肠外营养的日益普及，进一步推动了全球市场成长。此外，慢性疾病（尤其是癌症和疾病相关营养不良）的盛行率上升，也推动了对肠外营养的需求。这些患者常出现胃肠功能障碍或治疗相关併发症，限制了口服或经肠营养。癌症治疗，例如化疗和放射线治疗，通常需要静脉营养支持。例如，美国国家癌症研究所 (NCI) 估计，到 2026 年，美国将新增 2,114,850 例癌症病例，并有 626,140 例癌症相关死亡病例，这凸显了需要肠外营养的患者群体日益增长。

肠外营养具有诸多优势，包括使用方便、改善胃部血流、高效输送营养物质、抑制肌肉分解代谢。在全球范围内，各种以营养为重点的健康意识宣传活动以及旨在促进健康和社会福祉的各项倡议正在进行，预计这些都将推动市场成长。例如，印度于2023年9月启动了「营养月」（POSHAN Maah）。这体现了印度政府的旗舰计画「营养运动」（POSHAN Abhiyaan），该计画旨在意识提升，并改善他们的营养状况。

营养支持疗法（PN）也适用于患有疾病或健康问题、需要特殊营养管理的婴儿童。 2023年，欧洲特殊营养协会（SNE）估计，欧盟约有30万名儿童需要医疗营养，以满足婴幼儿早期的特殊医疗需求，并支持其生长发育。此外，同一项研究发现，约40%的住院成年患者存在营养不良，需要医疗营养来控制疾病相关的营养不良并缩短住院时间。为了降低感染疾病风险和发育不良，PN正在全球越来越广泛的应用。

为了提高安全性、效率和临床疗效，肠外营养供应商越来越重视即用型多腔输液袋、先进的脂肪乳剂和病患特异性配方。百特和费森尤斯卡比等公司提供多种专业解决方案，例如新生儿专用“Numeta”、成人专用“Kabiven”以及富含混合油脂和Omega-3的脂肪乳剂“SMOFlipid/Omegaven”，后者旨在支持代谢功能并减少併发症。随着产业转向以规范为主导、以患者为中心的营养管理模式转变，无论是在医院还是门诊，人们也越来越关注新生儿和儿童的个人化肠外营养、居家肠外营养以及简化的输液流程。

许多早产儿出生体重偏低，免疫系统发育不全，面临严重的健康风险。个人和医疗机构都非常关注降低早产相关死亡率，这推动了静脉注射脂肪乳剂的使用。根据美国疾病管制与预防中心（CDC）的数据显示，2022年美国的早产率约为10.4%。此外，同期非裔美国女性的早产率约为14.6%。如此高的早产率预计将推动市场扩张。

目录

第一章：调查方法和范围

第二章执行摘要

第三章 肠外营养市场：变数、趋势与范围

  • 市场谱系展望
  • 产业特定分析
  • 技术展望
  • 法律规范
  • 市场动态
  • 肠外营养市场分析工具

第四章 肠外营养市场：依营养素类型分類的估算与趋势分析

  • 按营养素类型分類的市场份额分析（2025 年和 2033 年）
  • 肠外营养市场：依营养素类型划分，2021-2033年
  • 碳水化合物
  • 肠外脂肪乳剂
  • 单剂量氨基酸溶液
  • 微量元素
  • 维生素和矿物质

第五章 肠外营养市场：依阶段类型分類的估算与趋势分析

  • 按阶段类型分類的市场份额分析（2025 年和 2033 年）
  • 肠外营养市场：按阶段和类型划分，2021-2033年
  • 成人
  • 儿童

第六章 肠外营养市场：依适应症分類的估计与趋势分析

  • 按适应症分類的市场份额分析，2025 年和 2033 年
  • 肠外营养市场：依适应症划分，2021-2033年
  • 阿兹海默症
  • 营养缺乏
  • 癌症治疗
  • 糖尿病
  • 慢性肾臟病
  • 罕见疾病
  • 吞嚥困难
  • 疼痛管理
  • 吸收不良/消化系统疾病/腹泻
  • 其他的

第七章 肠外营养市场：依销售管道分類的估算与趋势分析

  • 按销售管道分類的市场份额分析（2025 年和 2033 年）
  • 肠外营养市场：依销售管道划分，2021-2033年
  • 在线的
  • 零售
  • 对于医疗机构

第八章 肠外营养市场：区域估算与趋势分析

  • 2025年及2033年区域市占率分析
  • 区域市场概览
  • 区域市场概述
  • 2025 年及 2033 年各地区肠外营养市场展望
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • UAE
    • 南非
    • 科威特

第九章 竞争情势

  • 主要市场参与企业的最新趋势及影响分析
  • 公司分类
  • 企业市场占有率分析，2025 年
  • Company Position Analysis, 2025
  • 公司简介
    • Baxter
    • Otsuka Pharmaceutical Factory, Inc.
    • Grifols, SA
    • B. Braun Melsungen AG
    • Vifor Pharma（Acquired by CSL）
    • Fresenius Kabi AG
    • Sichuan Kelun Pharmaceutical Co., Ltd.
    • Pfizer Inc.（Hospira Inc.）
    • ICU Medical, Inc.
    • JW Pharmaceutical
    • Aculife
Product Code: 978-1-68038-867-1

Parenteral Nutrition Market Summary

The global parenteral nutrition market size was estimated at USD 7.97 billion in 2025 and is projected to reach USD 12.59 billion by 2033, growing at a CAGR of 5.87% from 2026 to 2033. This growth is attributed to the rising prevalence of gastrointestinal disorders, increasing premature births, and the growing incidence of chronic diseases such as cancer.

Expanding hospital infrastructure, advancements in nutrient formulations, and increasing adoption of home parenteral nutrition further support market growth globally. Moreover, the rising prevalence of chronic conditions, particularly cancer and disease-related malnutrition, is driving demand for parenteral nutrition, as these patients often experience gastrointestinal dysfunction or treatment-related complications that limit oral or enteral feeding. Cancer therapies such as chemotherapy and radiation frequently necessitate intravenous nutritional support; for instance, the National Cancer Institute estimates 2,114,850 new cancer cases and 626,140 cancer deaths in the U.S. in 2026, highlighting the growing patient base requiring parenteral nutrition.

Numerous benefits accompany parenteral nutrition, including ease of use, stimulation of stomach blood flow, efficient nutrient delivery, and preservation of muscle catabolism. Globally, various health awareness campaigns, with a particular emphasis on nutrition, are underway, along with diverse initiatives promoting health and social care, expected to bolster market growth. For example, India observed POSHAN Maah in September 2023, mirroring the Government of India's flagship program, POSHAN Abhiyaan, aimed at raising awareness and enhancing nutritional outcomes for pregnant women, children under six years of age, and lactating mothers.

PN also has applications for infants and children suffering from a disease or medical condition, thereby requiring special nutritional management. In 2023, Specialized Nutrition Europe (SNE) estimated that nearly 300,000 EU children are anticipated to require medical nutrition for their special medical needs in early life stages, which supports growth and development. The study further reveals that about 40% of hospitalized adult patients are malnourished and need medical nutrition to manage the disease-related malnutrition condition, thereby reducing the duration of hospital stay. PN lowers the infection risk and underdevelopment, thereby promoting its adoption worldwide.

Parenteral nutrition providers are increasingly focusing on ready-to-use multi-chamber bags, advanced lipid emulsions, and patient-specific formulations to improve safety, efficiency, and clinical outcomes. Companies like Baxter and Fresenius Kabi offer specialized solutions such as Numeta for neonates, Kabiven for adults, and SMOFlipid/Omegaven lipid emulsions enriched with mixed oils and omega-3s to support metabolic function and reduce complications. There is also a growing emphasis on tailored neonatal and pediatric PN, home parenteral nutrition, and streamlined infusion workflows, reflecting the industry's shift toward protocol-driven, patient-centric nutrition management across hospital and outpatient settings.

Many premature babies experience low weight and underdeveloped immunity, placing them at significant risk. There is extensive focus from individuals and healthcare authorities on reducing mortality associated with preterm birth, which drives the utilization of parenteral lipid emulsions. According to the U.S. Centers for Disease Control and Prevention (CDC), the preterm birth rate in the country was approximately 10.4% in 2022. In addition, during the same period, the preterm birth rate for African American women was around 14.6%. These elevated preterm birth rates are expected to bolster market expansion.

Global Parenteral Nutrition Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global parenteral nutrition market report based on nutrient type, stage type, indication, sales channel, and region:

  • Nutrient Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Trace Elements
  • Vitamins & Minerals
  • Stage Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Adult
  • Pediatrics
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others
  • Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Online
  • Retail
  • Institutional
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • China
    • India
    • Japan
    • Thailand
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Nutrition Type Outlook
    • 2.2.2. Stage Type Outlook
    • 2.2.3. Indication Outlook
    • 2.2.4. Sales Channel Outlook
  • 2.3. Competitive Insights

Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Industry Analysis
    • 3.2.1. User Perspective Analysis
    • 3.2.2. Key End Users
  • 3.3. Technology Outlook
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Drivers Analysis
      • 3.5.1.1. Rising Prevalence of Gastrointestinal Disorders and Malabsorption Conditions
      • 3.5.1.2. Increasing Number of Preterm Births Requiring Neonatal Nutritional Support
      • 3.5.1.3. Growing Incidence of Cancer and Demand for Clinical Nutritional Support
      • 3.5.1.4. Expansion of Home Parenteral Nutrition (HPN) Programs
      • 3.5.1.5. Rising Hospital Admissions and Critical Care Patient Population
      • 3.5.1.6. Increasing Awareness of Clinical Nutrition in Disease Management
      • 3.5.1.7. Growing Geriatric Population with Nutritional Deficiencies
    • 3.5.2. Market Restraints Analysis
      • 3.5.2.1. Stringent Regulatory Requirements for Sterile Compounding
      • 3.5.2.2. Risk of Metabolic and Liver-Related Complications
    • 3.5.3. Industry Challenges and Opportunity Analysis
  • 3.6. Parenteral Nutrition Market Analysis Tools
    • 3.6.1. Porter's Analysis
      • 3.6.1.1. Bargaining power of the suppliers
      • 3.6.1.2. Bargaining power of the buyers
      • 3.6.1.3. Threats of substitution
      • 3.6.1.4. Threats from new entrants
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic and Social landscape
      • 3.6.2.3. Technological landscape
      • 3.6.2.4. Environmental landscape
      • 3.6.2.5. Legal landscape

Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Nutrient Type Market Share Analysis, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Parenteral Nutrition Market: By Nutrient Type, 2021 to 2033
  • 4.5. Carbohydrates
    • 4.5.1. Carbohydrates Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Parenteral Lipid Emulsion
    • 4.6.1. Parenteral Lipid Emulsion Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Single Dose Amino Acid Solution
    • 4.7.1. Single Dose Amino Acid Solution Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Trace Elements
    • 4.8.1. Trace Elements Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Vitamins & Minerals
    • 4.9.1. Vitamins & Minerals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Stage Type Market Share Analysis, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Parenteral Nutrition Market: By Stage Type, 2021 to 2033
  • 5.5. Adult
    • 5.5.1. Adult Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Pediatric
    • 5.6.1. Pediatric Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Indication Market Share Analysis, 2025 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Parenteral Nutrition Market: By Indication, 2021 to 2033
  • 6.5. Alzheimer's
    • 6.5.1. Alzheimer's Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Nutrition Deficiency
    • 6.6.1. Nutrition Deficiency Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Cancer Care
    • 6.7.1. Cancer Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Diabetes
    • 6.8.1. Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Chronic Kidney Disease
    • 6.9.1. Chronic Kidney Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Orphan Diseases
    • 6.10.1. Orphan Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. Dysphagia
    • 6.11.1. Dysphagia Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.12. Pain Management
    • 6.12.1. Pain Management Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.13. Malabsorption/GI Disorder/Diarrhea
    • 6.13.1. Malabsorption/GI Disorder/Diarrhea Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.14. Others
    • 6.14.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates& Trend Analysis

  • 7.1. Definition and Scope
  • 7.2. Sales Channel Market Share Analysis, 2025 & 2033
  • 7.3. Segment Dashboard
  • 7.4. Parenteral Nutrition Market: By Sales Channel, 2021 to 2033
  • 7.5. Online
    • 7.5.1. Online Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Retail
    • 7.6.1. Retail Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Institutional
    • 7.7.1. Institutional Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis by Country, Nutrient Type, Stage Type, Indication, and Sales Channel

  • 8.1. Definition and Scope
  • 8.2. Regional Market Share Analysis, 2025 & 2033
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. Parenteral Nutrition Market Share, By Region, 2025 & 2033 (USD Million)
  • 8.6. North America
    • 8.6.1. North America Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. U.S.
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. U.S. Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Canada
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. Canada Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. Mexico
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. Mexico Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Europe
    • 8.7.1. Europe Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. UK
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. UK Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Germany
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Germany Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. France
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.4.3. Competitive Insights
      • 8.7.4.4. France Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Italy
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.5.3. Competitive Insights
      • 8.7.5.4. Italy Parenteral Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Spain
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.6.3. Competitive Insights
      • 8.7.6.4. Spain Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.7. Sweden
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.7.3. Competitive Insights
      • 8.7.7.4. Sweden Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.8. Denmark
      • 8.7.8.1. Key Country Dynamics
      • 8.7.8.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.8.3. Competitive Insights
      • 8.7.8.4. Denmark Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.9. Norway
      • 8.7.9.1. Key Country Dynamics
      • 8.7.9.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.9.3. Competitive Insights
      • 8.7.9.4. Norway Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Asia Pacific
    • 8.8.1. Asia Pacific Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. China
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. China Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Japan
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Japan Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. India
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. India Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. South Korea
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. South Korea Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.6. Australia
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.6.3. Competitive Insights
      • 8.8.6.4. Australia Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.7. Thailand
      • 8.8.7.1. Key Country Dynamics
      • 8.8.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.7.3. Competitive Insights
      • 8.8.7.4. Thailand Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.9. Latin America
    • 8.9.1. Latin America Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.9.2. Brazil
      • 8.9.2.1. Key Country Dynamics
      • 8.9.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.2.3. Competitive Insights
      • 8.9.2.4. Brazil Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.9.3. Argentina
      • 8.9.3.1. Key Country Dynamics
      • 8.9.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.3.3. Competitive Insights
      • 8.9.3.4. Argentina Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.10. Middle East and Africa
    • 8.10.1. Middle East and Africa Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.10.2. Saudi Arabia
      • 8.10.2.1. Key Country Dynamics
      • 8.10.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.2.3. Competitive Insights
      • 8.10.2.4. Saudi Arabia Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.10.3. UAE
      • 8.10.3.1. Key Country Dynamics
      • 8.10.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.3.3. Competitive Insights
      • 8.10.3.4. UAE Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.10.4. South Africa
      • 8.10.4.1. Key Country Dynamics
      • 8.10.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.4.3. Competitive Insights
      • 8.10.4.4. South Africa Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.10.5. Kuwait
      • 8.10.5.1. Key Country Dynamics
      • 8.10.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.5.3. Competitive Insights
      • 8.10.5.4. Kuwait Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis, 2025
  • 9.4. Company Position Analysis, 2025
  • 9.5. Company Profiles
    • 9.5.1. Baxter
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Otsuka Pharmaceutical Factory, Inc.
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Grifols, S.A.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. B. Braun Melsungen AG
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Vifor Pharma (Acquired by CSL)
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Fresenius Kabi AG
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Sichuan Kelun Pharmaceutical Co., Ltd.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Pfizer Inc. (Hospira Inc.)
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. ICU Medical, Inc.
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. JW Pharmaceutical
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Aculife
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Financial Performance
      • 9.5.11.3. Product Benchmarking
      • 9.5.11.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 4 North America Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 5 North America Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 6 North America Parenteral nutrition market estimates and forecasts by sales channel, 2021 - 2033 (USD Million)
  • Table 7 U.S. Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 8 U.S. Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 9 U.S. Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 10 U.S. Parenteral nutrition market estimates and forecasts by sales channel, 2021 - 2033 (USD Million)
  • Table 11 Canada Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 12 Canada Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 13 Canada Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 14 Canada Parenteral nutrition market estimates and forecasts by sales channel, 2021 - 2033 (USD Million)
  • Table 15 Mexico Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 16 Mexico Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 17 Mexico Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 18 Mexico Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 19 Europe Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 20 Europe Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 21 Europe Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 22 Europe Parenteral nutrition market estimates and forecasts by sales channel, 2021 - 2033 (USD Million)
  • Table 23 UK Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 24 UK Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 25 UK Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 26 UK Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 27 Germany Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 28 Germany Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 29 Germany Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 30 Germany Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 31 France Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 32 France Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 33 France Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 34 France Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 35 Italy Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 36 Italy Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 37 Italy Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 38 Italy Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 39 Spain Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 40 Spain Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 41 Spain Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 42 Spain Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 43 Sweden Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 44 Sweden Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 45 Sweden Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 46 Sweden Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 47 Denmark Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 48 Denmark Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 49 Denmark Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 50 Denmark Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 51 Norway Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 52 Norway Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 53 Norway Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 54 Norway Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 55 Asia Pacific Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 56 Asia Pacific Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 59 Japan Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 60 Japan Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 61 Japan Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 62 Japan Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 63 China Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 64 China Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 65 China Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 66 China Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 67 India Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 68 India Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 69 India Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 70 India Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 71 Australia Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 72 Australia Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 73 Australia Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 74 Australia Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 75 South Korea Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 76 South Korea Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 77 South Africa Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 78 South Korea Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 79 Thailand Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 80 Thailand Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 81 Thailand Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 82 Thailand Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 83 Latin America Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 84 Latin America Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 85 Latin America Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 86 Latin America Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 87 Brazil Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 88 Brazil Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 89 Brazil Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 90 Brazil Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 91 Argentina Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 92 Argentina Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 93 Argentina Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 94 Argentina Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 95 MEA Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 96 MEA Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 97 MEA Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 98 MEA Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 99 South Africa Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 100 South Africa Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 101 South Africa Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 102 South Africa Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 103 Saudi Arabia Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 104 Saudi Arabia Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 105 Saudi Arabia Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 106 Saudi Arabia Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 107 UAE Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 108 UAE Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 109 UAE Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 110 UAE Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 111 Kuwait Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 112 Kuwait Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 113 Kuwait Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 114 Kuwait Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 Parenteral Nutrition Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (1/2)
  • Fig. 9 Segment Snapshot (2/2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 Parenteral Nutrition- Market Size and Growth Prospects (USD Million)
  • Fig. 12 Parenteral Nutrition Market: Industry Value Chain Analysis
  • Fig. 13 Parenteral Nutrition Market: Market Dynamics
  • Fig. 14 Parenteral Nutrition Market: PORTER's Analysis
  • Fig. 15 Parenteral Nutrition Market: PESTEL Analysis
  • Fig. 16 Parenteral Nutrition Market Share by Nutrient Type 2025 & 2033 (USD Million)
  • Fig. 17 Parenteral Nutrition Market, by Nutrient Type: Market Share, 2025 & 2033
  • Fig. 18 Carbohydrates Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Parenteral Lipid Emulsion Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Single Dose Amino Acid Solution Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Trace Elements Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Vitamins & Minerals Market Estimates & Forecasts, 2021 - 2033 (USD Million
  • Fig. 23 Parenteral Nutrition Market, By Stage Type: Key Takeaways
  • Fig. 24 Parenteral Nutrition Market, By Stage Type: Market Share, 2025 & 2033
  • Fig. 25 Adult Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Pediatric Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Parenteral Nutrition Market Share by Indication 2025 & 2033 (USD Million)
  • Fig. 28 Parenteral Nutrition Market, by Indication: Market Share, 2025 & 2033
  • Fig. 29 Pediatric Alzheimer's Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Nutrition Deficiency Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Cancer Care Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Diabetes Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Chronic Kidney Disease Market Estimates & Forecasts, 2021 - 2033 (USD Million
  • Fig. 34 Orphan Disease Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Dysphagia Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Pain Management Market Estimates & Forecasts, 2021 - 2033 (USD Million
  • Fig. 37 Malabsorption/GI.Disorder/Diarrhea Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Others Market Estimates & Forecasts, 2021 - 2033 (USD Million
  • Fig. 39 Parenteral Nutrition Market, by Sales Channel: Key Takeaways
  • Fig. 40 Parenteral Nutrition Market, by Sales Channel: Market Share, 2025 & 2033
  • Fig. 41 Online Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Retail Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Institutional Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Parenteral Nutrition Market Revenue, by Region, 2025 & 2033 (USD Million)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 Regional Marketplace: Key Takeaways
  • Fig. 47 North America Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 U.S. Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Canada Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Mexico Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Europe Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 UK Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Germany Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 France Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 ItalyParenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Spain Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Denmark Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Norway Parenteral Nutrition Market Estimates and Forecasts, (2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific Parenteral Nutrition Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 61 China Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Japan Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 India Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 South Korea Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Thailand Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Australia Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Latin America Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Brazil Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Mexico Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Argentina Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 MEA Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Saudi Arabia Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 UAE Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 South Africa Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Kuwait Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key Company Categorization
  • Fig. 77 Company Market Positioning
  • Fig. 78 Key Company Market Share Analysis, 2025
  • Fig. 79 Strategic Framework